Association of the leptin receptor Q223R (rs1137101) polymorphism with obesity measures in Sri Lankans by Illangasekera, Y.A. et al.
Association of the leptin receptor Q223R (rs1137101) 
polymorphism with obesity measures in Sri Lankans
ILLANGASEKERA, Y.A., KUMARASIRI, P.V.R., FERNANDO, D.J. and 
DALTON, C.F. <http://orcid.org/0000-0002-1404-873X>
Available from Sheffield Hallam University Research Archive (SHURA) at:
http://shura.shu.ac.uk/25872/
This document is the author deposited version.  You are advised to consult the 
publisher's version if you wish to cite from it.
Published version
ILLANGASEKERA, Y.A., KUMARASIRI, P.V.R., FERNANDO, D.J. and DALTON, C.F. 
(2020). Association of the leptin receptor Q223R (rs1137101) polymorphism with 
obesity measures in Sri Lankans. BMC research notes, 13 (1), p. 34. 
Copyright and re-use policy
See http://shura.shu.ac.uk/information.html
Sheffield Hallam University Research Archive
http://shura.shu.ac.uk
Illangasekera et al. BMC Res Notes           (2020) 13:34  
https://doi.org/10.1186/s13104-020-4898-4
RESEARCH NOTE
Association of the leptin receptor Q223R 
(rs1137101) polymorphism with obesity 
measures in Sri Lankans
Y. A. Illangasekera1* , P. V. R. Kumarasiri2, D. J. Fernando3 and C. F. Dalton4
Abstract 
Objective: The role of genetic factors in the development of obesity is largely unreported in Sri Lankans. The Q223R 
(rs1137101) single nucleotide polymorphism (SNP) of the leptin receptor (LEPR) gene has been associated with obe-
sity measures in various ethnicities. We investigated the association of the Q223R polymorphism with obesity related 
anthropometric measures and biochemical parameters fasting blood glucose and lipid profile in a sample of 530 Sri 
Lankan adult subjects (age 18–70 years) representing both urban and rural areas of residence.
Results: The LEPR Q223R variant G allele frequency was 0.54. The polymorphism was associated with body mass 
index (p = 0.04) and waist circumference (p = 0.02) measures in overweight and obese (BMI ≥ 25 kgm−2) subjects with 
the variant allele conferring a greater risk of adiposity. Residency in urban areas eliminated the protective effect of the 
non-risk genotype (AA) in the development of obesity.
Keywords: Obesity, Genetics, Polymorphism, Leptin receptor
© The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, 
adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and 
the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material 
in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material 
is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the 
permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco 
mmons .org/licen ses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/publi cdoma in/
zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Introduction
Obesity is currently a global epidemic and Sri Lanka too 
has seen a dramatic rise in the rates of obesity over the 
past 3 decades [1]. Rapid advances in the fields of genet-
ics and molecular biology have lead to the discovery of 
many genetic variants associated with obesity and adi-
posity related quantitative traits. However the effect of 
common genetic variants in the development of complex 
obesity is largely unreported in Sri Lankans.
The leptin hormone is secreted in proportion to the 
adipose tissue mass and indicates the nutritional status 
to the brain. Leptin acts through the leptin receptors 
which are located in the hypothalamus which is the cen-
tral regulatory centre of energy homeostasis and appetite 
regulation. The leptin receptors are encoded by the LEPR 
gene located in chr1p31. Mutations of the LEPR gene are 
associated with monogenic forms of severe early onset 
obesity and hyperphagia [2]. A number of SNPs of the 
coding region of the LEPR gene have been described [3]. 
Of these the Q223R (dbSNP:rs1137101) polymorphism 
occurs as a result of a non-conservative A to G substi-
tution at codon 223 resulting in a glutamine to arginine 
amino acid change. This functional variant reduces leptin 
binding and thus impairs leptin signaling [4]. Numerous 
studies in various populations have replicated the asso-
ciation with Q223R SNPs with obesity measures with the 
variant G allele conferring a greater risk [5, 6]. Through 
the present study we aimed to replicate the associa-
tion between the LEPR Q223R SNP with obesity related 
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The study was conducted in the Kandy district of Sri 
Lanka. A multi-stage random sampling method using 
names from electoral lists was used to select 530 study 
subjects (age 18–70  years) from the adult general pop-
ulation representative of 6 administrative divisions 
covering both urban and rural areas of residence. Preg-
nant women, women up to 3  months postpartum and 
those suffering from pathological forms of obesity were 
excluded from the study by examining medical records 
where available.
Genotyping
DNA was extracted from whole blood using QIAamp 
DNA Midi kits (QIAGEN, Germany) according to the 
manufacturer’s protocol. Genotyping was performed by 
real-time PCR and allelic discrimination using Taqman 
assays (Applied Biosystems, Foster city, CA). Real-Time 
PCR was performed in a 96-well format in a total 10 µl 
reaction volume using VIC/FAM dye labelled allelic 
probes with Taqman GTXpress Master Mix. The reaction 
mixture was subjected to a standard thermal protocol of 
95 °C for 10 min, 40 cycles of 95 °C for 15 s and 60 °C for 
1 min in the StepOnePlus© Thermocycler (Applied Bio-
systems, Foster city, CA). Genotyping quality control was 
performed by duplicating each sample and including two 
negative controls for each 96-well plate.
Serum biochemistry analysis for FBS (Fasting Blood 
Sugar) and lipid profile parameters was conducted using 
the Indiko™ (Thermo Fisher Scientific, USA) fully auto-
mated clinical and specialty chemistry analyser. Bio-
chemical analysis was performed within a few hours of 
samples collection.
Data analysis
Statistical analysis was performed using SPSS ver.17 
(IBM) software. Genotype numbers were determined 
manually from the allelic discrimination plots and allele 
frequencies were determined from the genotype frequen-
cies. The genetic association analysis was performed 
assuming an additive genetic model. Calculation for 
deviation from Hardy–Weinberg equilibrium was per-
formed using Pearson’s Chi square test. Non-normal 
distributions of data were corrected by log transforma-
tion. Comparisons of means were performed using the 
student’s t-test, ANOVA or ANCOVA models where 
covariate adjustments were required. We also investi-
gated the potential moderating effect of area of residence 
(urban/rural) on the association between SNPs and body 
mass index (BMI). Thus two-way factorial ANOVA was 
used to investigate interactions. Overweight and obesity 
were defined as a BMI ≥ 25 kgm−2 and BMI ≥ 30 kgm−2 
respectively. All p values < 0.05 were considered 
significant.
Results
The study sample comprised of 324 (61.1%) females. 
Overweight or obesity was observed in 264 (49.8%) of 
the study population. The baseline characteristics of the 
study population are displayed in Table  1. Significant 
gender differences in waist-to-hip (WHR), high density 
lipoprotein (HDL) and triglyceride (TGL) values were 
observed with higher values in males for WHR and TGL. 
Rural populations represented 71.6% of the study cohort. 
Urban (U) dwellers recorded significantly higher obe-
sity measures compared to rural (R) dwellers for BMI 
(U:25.7 ± 4.3  kgm−2, R:24.7 ± 4.1  kgm−2, p < 0.05), Waist 
Circumference (WC) (U:92.2 ± 10.7 cm, R:88.1 ± 10.6 cm, 
p < 0.01) and WHR (U:0.94 ± 0.07, R:0.91 ± 0.07, p < 0.01).
The variant G allele frequency was 0.54. The observed 
genotype frequencies did not show significant devia-
tion from the Hardy–Weinberg equilibrium (p = 0.44). 
There were also no significant differences in the dis-
tribution of genotype frequencies between genders 
(X2 (2) = 1.32, p = 0.52).The association between LEPR 
Q223R and obesity and biochemical measures in the 
overall and overweight or obese population are displayed 
in Table  2. In the overall study population as well as in 
gender specific subgroup analysis, no significant associa-
tions between LEPR genotypes and BMI, WC, WHR or 
biochemical parameters were found. However when the 
analysis was conducted in overweight and obese subjects 
only (BMI ≥ 25  kgm−2), significant differences in BMI 
(p = 0.04) and WC (p = 0.02) values were observed. Post 
hoc analysis with Bonferroni correction revealed that 
Table 1 Baseline characteristics of study population
Data shown as mean ± SD; FBS, HDL-C and TGL log transformed for analysis
BMI body mass index, WC waist circumference, WHR waist-to-hip ratio, 
FBS fasting blood sugar, TC total cholesterol, LDL-C low density lipoprotein 
cholesterol, HDL-C high density lipoprotein cholesterol, TGL triglycerides
Male (n = 206) Female 
(n = 324)
p Total (530)
Age (years) 47.6 ± 11.0 47.5 ± 11.3 0.86 47.5 ± 11.2
BMI (kg/m2) 24.7 ± 3.8 25.2 ± 4.4 0.13 25.0 ± 4.2
WC(cm) 90.0 ± 10.4 88.7 ± 11.0 0.18 89.2 ± 10.8
WHR 0.95 ± 0.06 0.91 ± 0.07 < 0.001 0.92 ± 0.07
FBS (mmol/l) 5.4 ± 2.5 5.5 ± 3.7 0.77 5.5 ± 3.2
TC (mmol/l) 5.1 ± 1.1 5.8 ± 1.6 0.30 5.7 ± 1.5
LDL-C (mmol/l) 3.8 ± 2.4 3.8 ± 2.1 0.88 3.8 ± 2.2
HDL-C (mmol/l) 1.4 ± 1.7 1.4 ± 0.3 < 0.001 1.4 ± 1.1
TGL (mmol/l) 3.5 ± 1.7 3.2 ± 2.1 < 0.05 3.4 ± 2.0
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homozygous carriers of G allele (Arg/Arg) recorded sig-
nificantly greater BMI values (M(SE) = 1.3 kgm−2 (0.53)) 
compared to the AA (Gln/Gln) carriers (p = 0.04). The 
GG carries recorded significantly higher WC values com-
pared to the AG carriers (M(SE) = 2.8 cm (1.1), p = 0.04) 
as well as the AA carriers (M(SE) = 3.8 cm (1.4), p = 0.03). 
No significant associations were observed when the 
analysis was conducted for the obese group based on 
the World Health Organization (WHO) definition of 
BMI ≥ 30 kgm−2.
The effect of area of residence on the relationship 
between LEPR status and BMI in the total study popu-
lation was investigated. The variant allele carriers were 
considered as a single group (GG + AG) and compared 
against the non-risk (AA) group for the analysis. Whilst 
the risk allele carriers (GG + AG) had significantly greater 
BMI values compared to the AA carriers in rural popu-
lations (mean difference = 1.2  kgm−2 (95%CI 0.15–2.3), 
p = 0.03) this difference was not observed in the urban 
group. Whilst both genotype groups showed greater BMI 
values in urban populations, the non-risk (AA) genotypes 
showed a highly significant increase BMI value in urban 
areas (Mean difference = 2.2  kgm−2 (95%CI 0.5–3.9), 
p < 0.01) whilst the risk genotypes (GG + AG) showed an 
increase which was marginally insignificant (BMI differ-
ence = 0.8 kgm−2 (95%CI − 0.1–1.7), p = 0.08).
Discussion
We conducted a population based study to investigate the 
potential association between the LEPR Q223R SNP and 
obesity related measures in Sri Lankans. The study sam-
ple was recruited randomly from the adult general popu-
lation and represented a wide age range of 18–70 years. 
The sample also represented residents from both urban 
and rural populations. These facts make the findings of 
the study highly generalizable to the true population. Our 
results demonstrate that the presence of the variant `G 
allele’ of the LEPR Q223R polymorphism is associated 
with greater BMI and WC measures and these associa-
tions are most prominent in subjects with a BMI greater 
than 25  kgm−2. Similar results have been reported pre-
viously where the association between the `G’ allele and 
obesity related anthropometric measures were observed 
only in obese subjects [7]. When the entire study popu-
lation was analyzed a trend for increasing BMI and WC 
was evident with the `G’ allele carriers though these asso-
ciations did not reach statistical significance. Our find-
ings indicate that the effects of the LEPR polymorphism 
on obesity is accentuated in higher BMI groups and that 
factors which are potentially protective against obesity 
(i.e. physical activity, diet) may attenuate the obesogenic 
effects of the gene variant. Though the sample size was 
somewhat moderate in the present study positive asso-
ciations between the LEPR Q223R polymorphism and 
obesity have been reported even in smaller study groups 
in other ethnic populations [7, 8]. Therefore the results 
indicate a degree of ethnic heterogeneity in the effect of 
the polymorphism.
In the analysis of association with biochemical param-
eters we found no association between the LEPR poly-
morphism and FBS or lipid measures. The LEPR Q223R 
polymorphism has been reported to be associated with 
FBS and lipid measures in certain studies [7, 9, 10]. It 
should taken into perspective that due to the random 
selection of the study group, individuals currently on 
pharmacotherapy for type 2 diabetes and dyslipidaemia 
were also represented. In addition the biochemical meas-
ures tested are also influenced by lifestyle factors such as 
Table 2 Association of  LEPR rs1137101 with  obesity measures and  metabolic parameters in  the  overall study group 
and overweight or obese subjects (BMI ≥ 25 kgm−2)
Data shown as mean ± SD; FBS, HDL-C and TGL log transformed for analysis
BMI body mass index, WC waist circumference, WHR waist-to-hip ratio, FBS fasting blood sugar, TC total cholesterol, LDL-C low density lipoprotein cholesterol, HDL-C 
high density lipoprotein cholesterol, TGL triglycerides
p unadjusted; p* adjusted for age and gender
Overall study group Overweight or obese (BMI ≥ 25 kgm−2)
AA n = 107 AG n = 272 GG n = 151 p p* AA n = 53 AG n = 141 GG n = 70 p p*
BMI  (kgm−2) 24.4 ± 4.1 25.1 ± 4.1 25.2 ± 4.5 0.28 0.31 27.6 ± 2.6 28.2 ± 2.8 29.0 ± 3.3 0.03 0.04
WC(cm) 88.0 ± 10.7 89.4 ± 10.6 89.8 ± 11.3 0.41 0.36 95.2 ± 7.4 95.9 ± 7.7 98.4 ± 8.4 0.04 0.02
WHR 0.92 ± 0.07 0.92 ± 0.07 0.92 ± 0.06 0.78 0.94 0.94 ± 0.07 0.94 ± 0.07 0.94 ± 0.06 0.89 0.94
FBS (mmol/l) 5.3 ± 2.5 5.6 ± 3.9 5.2 ± 2.0 0.45 0.65 5.2 ± 1.9 5.6 ± 2.5 5.4 ± 2.2 0.53 0.52
TC (mmol/l) 5.5 ± 0.9 5.8 ± 1.2 5.8 ± 2.1 0.41 0.45 5.4 ± 1.0 5.8 ± 1.3 5.9 ± 2.7 0.18 0.19
LDL-C (mmol/l) 3.5 ± 0.9 3.8 ± 1.7 4.0 ± 3.3 0.19 0.19 3.4 ± 1.0 3.8 ± 2.2 4.5 ± 4.7 0.08 0.09
HDL-C (mmol/l) 1.3 ± 0.3 1.5 ± 1.5 1.4 ± 0.3 0.35 0.52 1.3 ± 0.3 1.4 ± 0.3 1.4 ± 0.3 0.16 0.38
TGL (mmol/l) 3.3 ± 1.6 3.4 ± 1.7 3.4 ± 2.6 0.49 0.56 3.3 ± 1.4 3.6 ± 1.8 3.8 ± 3.3 0.62 0.45
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diet and physical activity levels. Therefore potential asso-
ciation with the polymorphism may have been masked to 
a certain extent due to the aforementioned factors.
Finally we also investigated whether the effect of 
LEPR Q233R SNP genotype on obesity was influenced 
by urban/rural living. Our results demonstrated that 
benefits of having a lower BMI with the non-risk geno-
types (AA) was only present in rural populations and 
that urban living significantly narrowed the difference in 
BMI between the risk vs. non-risk genotypes. Therefore 
it could be postulated that factors unique to urban living 
may negate the beneficial effects of carrying the non-risk 
LEPR genotype. In fact urban living is known to be an 
independent risk factor for obesity in Sri Lankans [11]. 
The investigation of the mediating effects of factors such 
as diet and exercise on the association between LEPR 
polymorphisms and obesity outcomes is warranted in 
future studies.
In conclusion our study demonstrates that the LEPR 
Q223R SNP is associated with obesity measures in Sri 
Lankan populations and that the effects of the genotype 
vary according to the urban and rural areas of residence.
Limitations
The moderate sample size may have contributed to the 
lack of association seen in the overall study group. The 
effects of genetic variants on complex obesity are often 
small and require large sample numbers to detect statisti-
cally significant effects.
Abbreviations
SNP: single nucleotide polymorphism; LEPR: leptin receptor; BMI: body mass 
index; WC: waist circumference; WHR: waist to hip ratio; FBS: fasting blood 
sugar; TC: total cholesterol; LDL-C: low density lipoprotein cholesterol; HDL-C: 
high density lipoprotein cholesterol; TGL: triglycerides.
Acknowledgements
We thank all participants who volunteered for the study. We thank the Ministry 
of Higher Education, Sri Lanka and Sherwood Forest Hospitals NHS Founda-
tion Trust for funding. We thank Mr. D.M.S.N.B Dassanayake, technical officer, 
Faculty of Medicine, University of Peradeniya for laboratory assistance.
Authors’ contributions
All authors contributed to the design of the study. YAI performed data collec-
tion and genetic analysis. Data analysis was performed by YAI, PVRK and CFD. 
Writing of the draft manuscript was performed by YAI which was checked by 
DF and CFD. All authors read and approved the final manuscript.
Funding
The study was funded by a grant awarded to YAI by the Ministry of Higher 
Education Sri Lanka under the ‘Higher Education for the Twenty-first Century’ 
(HETC) project. The project proposal, data collection and laboratory methods, 
data analysis and results were approved by the same.
Availability of data and materials
The data sets of the current study are available from the corresponding author 
on reasonable request.
Ethics approval and consent to participate
Ethical clearance for the study was granted by the committee on research 
and ethical review of the Faculty of Medicine, University of Peradeniya, Sri 
Lanka (2011/EC/02). Patient information sheets and consent forms were also 
approved by the same ethical review body. All subjects provided written 




The authors declare that they have no competing interests.
Author details
1 Dept. of Pharmacology, Faculty of Medicine, University of Peradeniya, 
Peradeniya, Sri Lanka. 2 Dept. of Community Medicine, Faculty of Medicine, 
University of Peradeniya, Peradeniya, Sri Lanka. 3 Dept. of Diabetes and Endo-
crinology, Kings Mill Hospital, Sherwood Forest Hospitals NHS Foundation 
Trust, Sutton-in-Ashfield, UK. 4 Biomolecular Sciences Research Centre, Faculty 
of Health and Wellbeing, Sheffield Hallam University, Sheffield, UK. 
Received: 4 August 2019   Accepted: 8 January 2020
References
 1. Katulanada P, Jayawardena MAR, Sheriff MHR, Constantine GR, Matthews 
DR. Prevalence of overweight and obesity in Sri Lankan adults. Obes Rev. 
2010;11(11):751–6.
 2. Farooqi IS, Wangensteen T, Collins S, Kimber W, Matarese G, Keogh JM, 
et al. Clinical and molecular genetic spectrum of congenital deficiency of 
the leptin receptor. N Engl J Med. 2007;356(3):237–47.
 3. Gotoda T, Manning BS, Goldstone AP, Imrie H, Evans AL, Strosberg AD, 
et al. Leptin receptor gene variation and obesity: lack of association in a 
white British male population. Hum Mol Genet. 1997;6(6):869–76.
 4. Quinton ND, Lee AJ, Ross RJ, Eastell R, Blakemore AI. A single nucleotide 
polymorphism (SNP) in the leptin receptor is associated with BMI, fat 
mass and leptin levels in postmenopausal Caucasian women. Hum 
Genet. 2001;108(3):233–6.
 5. Yiannakouris N. The Q223R polymorphism of the leptin receptor gene is 
significantly associated with obesity and predicts a small percentage of 
body weight and body composition variability. J Clin Endocrinol Metab. 
2010;86(9):4434–9.
 6. Duarte SF, Francischetti EA, Genelhu VA, Cabello PH, Pimentel MM. LEPR 
p.Q223R, beta3-AR p.W64R and LEP c.-2548G > a gene variants in obese 
Brazilian subjects. Genet Mol Res. 2007;6(4):1035–43.
 7. Becer E, Mehmetcik G, Bareke H, Serakinci N. Association of leptin recep-
tor gene Q223R polymorphism on lipid profiles in comparison study 
between obese and non-obese subjects. Gene. 2013;529(1):16–20.
 8. Murugesan D, Arunachalam T, Ramamurthy V, Subramanian S. Associa-
tion of polymorphisms in leptin receptor gene with obesity and type 
2 diabetes in the local population of Coimbatore. Indian J Hum Genet. 
2010;16(2):72–7.
 9. Boumaiza I, Omezzine A, Rejeb J, Rebhi L, Ouedrani A, Ben Rejeb N, et al. 
Relationship between leptin G2548A and leptin receptor Q223R gene 
polymorphisms and obesity and metabolic syndrome risk in Tunisian 
volunteers. Genet Test Mol Biomarkers. 2012;16(7):726–33.
 10. Etemad A, Ramachandran V, Pishva SR, Heidari F, Aziz AF, Yusof AK, 
et al. Analysis of Gln223Agr polymorphism of leptin receptor gene 
in type II diabetic mellitus subjects among Malaysians. Int J Mol Sci. 
2013;14(9):19230–44.
 11. Arambepola CAS, Ekanayake R, Fernando D. Urban living and obesity: is it 
independent of its population and lifestyle characteristics? Trop Med Int 
Health. 2008;13(4):448–57.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
